SZSE:001367 (China)
Â
Ordinary Shares - Class A
Â¥
28.37
(-2.41%)
Dec 25
Business Description
Zhejiang Haisen Pharmaceutical Co Ltd
ISIN : CNE1000061L9
Share Class Description:
SZSE:001367: Ordinary Shares - Class ACompare
Compare
Traded in other countries / regions
001367.China IPO Date
2023-04-10Description
Zhejiang Haisen Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and intermediates.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 104.26 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.07 | |||||
| Interest Coverage | 426.24 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 19.98 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.6 | |||||
| 3-Year EBITDA Growth Rate | 9.2 | |||||
| 3-Year EPS without NRI Growth Rate | 9.8 | |||||
| 3-Year FCF Growth Rate | -30.1 | |||||
| 3-Year Book Growth Rate | 49.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.41 | |||||
| 9-Day RSI | 48.8 | |||||
| 14-Day RSI | 49.88 | |||||
| 6-1 Month Momentum % | 18.76 | |||||
| 12-1 Month Momentum % | -5.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 16.3 | |||||
| Quick Ratio | 14.38 | |||||
| Cash Ratio | 13.24 | |||||
| Days Inventory | 214.05 | |||||
| Days Sales Outstanding | 38.16 | |||||
| Days Payable | 51.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.72 | |||||
| Dividend Payout Ratio | 0.41 | |||||
| Forward Dividend Yield % | 1.72 | |||||
| 5-Year Yield-on-Cost % | 1.8 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 1.6 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.95 | |||||
| Operating Margin % | 28.17 | |||||
| Net Margin % | 27.56 | |||||
| FCF Margin % | 19.9 | |||||
| ROE % | 9.46 | |||||
| ROA % | 8.83 | |||||
| ROIC % | 30.59 | |||||
| ROC (Joel Greenblatt) % | 48.65 | |||||
| ROCE % | 10.78 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23.74 | |||||
| PE Ratio without NRI | 23.37 | |||||
| Price-to-Owner-Earnings | 22.92 | |||||
| PEG Ratio | 2.41 | |||||
| PS Ratio | 6.57 | |||||
| PB Ratio | 2.24 | |||||
| Price-to-Tangible-Book | 2.27 | |||||
| Price-to-Free-Cash-Flow | 32.95 | |||||
| Price-to-Operating-Cash-Flow | 17.47 | |||||
| EV-to-EBIT | 14.6 | |||||
| EV-to-EBITDA | 14.6 | |||||
| EV-to-Revenue | 4.65 | |||||
| EV-to-FCF | 23.37 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.65 | |||||
| Price-to-Graham-Number | 1.54 | |||||
| Price-to-Net-Current-Asset-Value | 2.64 | |||||
| Price-to-Net-Cash | 3.32 | |||||
| Earnings Yield (Greenblatt) % | 6.85 | |||||
| FCF Yield % | 2.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang Haisen Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 434.327 | ||
| EPS (TTM) (Â¥) | 1.195 | ||
| Beta | 0 | ||
| Volatility % | 40.57 | ||
| 14-Day RSI | 49.88 | ||
| 14-Day ATR (Â¥) | 1.036202 | ||
| 20-Day SMA (Â¥) | 28.8655 | ||
| 12-1 Month Momentum % | -5.14 | ||
| 52-Week Range (Â¥) | 17.939189 - 33.31 | ||
| Shares Outstanding (Mil) | 102.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhejiang Haisen Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhejiang Haisen Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhejiang Haisen Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhejiang Haisen Pharmaceutical Co Ltd(SZSE:001367)'s stock price today?
The current price of SZSE:001367 is ¥28.37. The 52 week high of SZSE:001367 is ¥33.31 and 52 week low is ¥17.94.
When is next earnings date of Zhejiang Haisen Pharmaceutical Co Ltd(SZSE:001367)?
The next earnings date of Zhejiang Haisen Pharmaceutical Co Ltd(SZSE:001367) is .
Does Zhejiang Haisen Pharmaceutical Co Ltd(SZSE:001367) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang Haisen Pharmaceutical Co Ltd(SZSE:001367) is 1.72% (As of Today), Highest Dividend Payout Ratio of Zhejiang Haisen Pharmaceutical Co Ltd(SZSE:001367) was 0.41. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Zhejiang Haisen Pharmaceutical Co Ltd(SZSE:001367) is 1.72%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers